The Application of ATP Bioluminescence In Vitro Tumor Chemosensitivity Assay in Breast Cancer

Objective To study whether ATP bioluminescence in vitro tumor chemosensitivity assay(ATP-TCA) can reflect the status of tumor chemosensitivity as they really are and the feasibility of designing chemotherapy based on ATP-TCA. Methods We tested the specimens from 42 breast cancer patients for chemosensitivity of 12 anticancer drugs using ATP-TCA. Results Available evaluation of specimen is 95%, PTX is the most sensitive drug to breast cancer and its in vitro effective rate is 93%, followed by ADM(67...